Suppr超能文献

PRKD1 启动子是胰腺癌中 KRas-NF-κB 通路的靶标。

The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer.

机构信息

Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL 32224, USA.

出版信息

Sci Rep. 2016 Sep 21;6:33758. doi: 10.1038/srep33758.

Abstract

Increased expression of PRKD1 and its gene product protein kinase D1 (PKD1) are linked to oncogenic signaling in pancreatic ductal adenocarcinoma, but a direct functional relationship to oncogenic KRas has not been established so far. We here describe the PRKD1 gene promoter as a target for oncogenic KRas signaling. We demonstrate that KRas-induced activation of the canonical NF-κB pathway is one mechanism of how PRKD1 expression is increased and identify the binding sites for NF-κB in the PRKD1 promoter. Altogether, these results describe a novel mechanism governing PRKD1 gene expression in PDA and provide a functional link between oncogenic KRas, NF-κB and expression of PRKD1.

摘要

PRKD1 及其基因产物蛋白激酶 D1(PKD1)的表达增加与胰腺导管腺癌中的致癌信号有关,但迄今为止尚未建立与致癌 KRas 的直接功能关系。我们在这里将 PRKD1 基因启动子描述为致癌 KRas 信号的靶标。我们证明 KRas 诱导的经典 NF-κB 途径的激活是 PRKD1 表达增加的一种机制,并确定了 PRKD1 启动子中 NF-κB 的结合位点。总的来说,这些结果描述了一种新的机制,该机制控制着 PDA 中 PRKD1 基因的表达,并为致癌 KRas、NF-κB 和 PRKD1 表达之间提供了功能联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94eb/5030668/bcca8d3c8e29/srep33758-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验